Concepedia

Bart Corsaro

BC

Statistics

Publications

2

Citations

156

H-Index

2

Active since

2019

Affiliations

BioMarin (United States)(Current)

National Institute for Biological Standards and Control

Roche Pharma AG (Germany)

Pfizer (United States)

Biogen (United States)

Bart Corsaro is an author at BioMarin (United States) specializing in biopharmaceutics, biomedical sciences, and quantitative assay validation.

Publications per year

2019–2021

2

Publications

2

2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)

Steven P. Piccoli, Devangi Mehta, Alessandra Vitaliti et al. · Bioanalysis · 2019 · 95 citations · Full text

, , +13

2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation ( <u>Part 3</u> –Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene &amp; Cell Therapy and Vaccine Assays)

Bart Corsaro, Tong‐Yuan Yang, Rocio Murphy et al. · Bioanalysis · 2021 · 61 citations · Full text

, , +17

1–2 of 2